Integrated CDMO Position Almac as a single partner across the drug development lifecycle, enabling clients to streamline vendor management and accelerate timelines. Emphasize the breadth from biomarker discovery through to commercial manufacturing, the global footprint, and a track record with 600+ customers over 55 years, aided by advanced capabilities like cGMP hydrogenation.

Clinical Trial Tech Leverage clinical technologies and trial management capabilities to upsell end-to-end trial services to sponsors seeking integrated workflows. Highlight randomisation and trial supply management, eCOA, data integration and biostatistical support, and the ability to run global trials with reliable supply chains.

ESG Partnerships Capitalize on ESG and education initiatives to differentiate as a values-aligned partner. Notable programs include Young Enterprise NI ESG backing, Farm to Fork outreach, and W5online STEM training partnerships, offering potential co-branded workforce development or sustainable supply chain programs for clients.

Financial Strength Advertise strong financial health and scale as a selling point for multi-year programs and large, complex projects. With revenue around a billion plus and substantial profitability, Almac can support long-duration collaborations, reduce program risk, and accommodate high touch, global manufacturing and clinical services.

Manufacturing Innovation Highlight advanced manufacturing capabilities such as cGMP flow hydrogenation and potent compound handling to attract clients needing specialized chemistry, process development and scalable manufacturing. Pair this with API, analytical, and biomarker capabilities to offer high-value, integrated development paths for next-gen therapies.